share_log

Northland Capital Markets Maintains Outperform on Cardlytics, Lowers Price Target to $7

Benzinga ·  Aug 9 01:25  · Ratings

Northland Capital Markets analyst Luke Horton maintains Cardlytics (NASDAQ:CDLX) with a Outperform and lowers the price target from $14 to $7.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment